Xtrackers Euro Stoxx 50 UCITS ETF 1D CHF is a equity ETF from Xtrackers tracking the Euro Stoxx 50 index through physical replication. Domiciled in Luxembourg and launched in 2007, the fund manages about 6 bn € and charges a TER of 0.09% — 9 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Xtrackers Euro Stoxx 50 UCITS ETF 1D CHF competes with 5 other products on the same index (Euro Stoxx 50): it ranks 2nd by fund size and 1st by ongoing cost, with a TER of 0.09% against a group median of 0.15%. It has been listed since 2007, 19 years of track record.
On a €10,000 investment the TER costs 9 € a year. The cheapest of the group is Xtrackers Euro Stoxx 50 UCITS ETF 1C CHF at 0.09%, or 9 € on the same amount: a difference of 0 € every year, roughly 0 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 42.6% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in CHF. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| ASML Holding N.V. | 7.6% |
| LVMH Moët Hennessy - Louis Vuitton | 6.2% |
| TotalEnergies SE | 5.2% |
| SAP SE | 4.2% |
| Sanofi SA | 3.9% |
| Siemens Aktiengesellschaft | 3.4% |
| LOréal S.A. | 3.2% |
| Allianz SE VNA O.N. | 3.1% |
| Schneider Electric S.E. | 3.0% |
| Air Liquide SA | 2.8% |
| Borsa Italiana | XESX | EUR |
| XETRA | DBXE | EUR |
| Francoforte | DBXE | EUR |
| London Stock Exchange | XESX | GBX |
| SIX Swiss Exchange | XESX | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.